Interleukin-1 favours the in vitro development of type 2 T helper (Th2) human T-cell clones

1994 ◽  
Vol 145 (2) ◽  
pp. 93-100 ◽  
Author(s):  
R. Manetti ◽  
V. Barak ◽  
M.-P. Piccinni ◽  
S. Sampognaro ◽  
P. Parronchi ◽  
...  
2004 ◽  
Vol 39 (4) ◽  
pp. 525-530 ◽  
Author(s):  
Orla Duggan ◽  
Paul Hyland ◽  
Kathryn Annett ◽  
Robin Freeburn ◽  
Christopher Barnett ◽  
...  

1988 ◽  
Vol 81 (1) ◽  
pp. 303 ◽  
Author(s):  
S. Romagnani ◽  
G.F. Del Prete ◽  
E. Maggi ◽  
P. Parronchi ◽  
A. Tiri ◽  
...  

1989 ◽  
Vol 70 (6) ◽  
pp. 1513-1521 ◽  
Author(s):  
H. Bunschoten ◽  
R. J. Klapmuts ◽  
I. J. Th. M. Claassen ◽  
S. D. Reyneveld ◽  
A. D. M. E. Osterhaus ◽  
...  

1984 ◽  
Vol 10 (2) ◽  
pp. 135-142 ◽  
Author(s):  
G. Pawelec ◽  
P. Wernet ◽  
A. Rehbein ◽  
I. Balko ◽  
E.M. Schneider

Blood ◽  
2009 ◽  
Vol 114 (7) ◽  
pp. 1423-1428 ◽  
Author(s):  
Ruth A. Ettinger ◽  
Eddie A. James ◽  
William W. Kwok ◽  
Arthur R. Thompson ◽  
Kathleen P. Pratt

AbstractThe development of neutralizing antibodies (inhibitors) after factor VIII (FVIII) infusions is a serious complication that affects approximately one-quarter of hemophilia A patients who have access to replacement therapy. To investigate the differentiation of naive T cells into FVIII-specific helper T cells that promote B-cell activation and antibody secretion, HLA-DRA-DRB1*0101-restricted T-cell clones that respond to a specific epitope in FVIII were isolated from a mild hemophilia A subject (the proband) 19 weeks and 21 months after his development of a high-titer inhibitor. Clones responding to the same epitope were also isolated from his multiply infused brother, who has not developed a clinically significant inhibitor. The 19-week proband clones were T helper (TH)17/TH1- or TH1/TH2-polarized, whereas all 8 clones isolated 21 months postinhibitor development were TH2-polarized cells. In contrast, all 6 clones from the brother who did not develop an inhibitor were TH1-polarized, indicating that tolerance to FVIII can be maintained even with circulating TH1-polarized cells that respond vigorously to in vitro FVIII stimulation. This is the first evidence that TH17/TH1-polarized cells play a role in hemophilic immune responses to FVIII. Furthermore, this is the first report of successful isolation and expansion of antigen-specific human TH17/TH1 clones using standard culture conditions.


1985 ◽  
Vol 162 (3) ◽  
pp. 1075-1080 ◽  
Author(s):  
R F Navarro ◽  
S T Jalkanen ◽  
M Hsu ◽  
G Søenderstrup-Hansen ◽  
J Goronzy ◽  
...  

To function efficiently in vivo, lymphocytes must circulate from the blood into lymphoid tissues and other sites of immune reaction. Herein, we show that human cytotoxic and helper T cell clones and lines, maintained in vitro with IL-2, express the functional capacity to recognize and bind to high endothelial venules (HEV), a capacity essential for lymphocyte exit from the blood, and hence for normal lymphocyte trafficking. The expression of functional homing receptors distinguishes human T cell clones from their murine counterparts, which uniformly lack receptors for HEV and are unable to migrate normally from the blood in vivo. The results raise the possibility that human T cell clones may be more effective in mediating in vivo immune responses than is suggested by murine models.


1985 ◽  
Vol 75 (1) ◽  
pp. 138
Author(s):  
B ZIMMERMAN ◽  
B UNDERDOWN ◽  
J ELLIS ◽  
O JAMES

Sign in / Sign up

Export Citation Format

Share Document